This product is supplied strictly for laboratory research use and is not approved for human or veterinary applications
Ryan said that we do need better evidence around whether some individuals can maintain weight loss after coming off GLP-1s, but she thinks what Calibrate is doing is sharing the decision-making with the patient and trying to adapt to the environment where drugs may not always be available. Since Calibrate has come onto the market, results were published from a much larger, peer-reviewed study funded by the Ozempic manufacturer Novo Nordisk in 2022
Clinicians considering GLP-1 receptor agonists for post-bariatric weight regain typically conduct a comprehensive assessment to identify contributing factors
There are two main methods of administration: Intravenous (IV): Delivered directly into a vein for maximum efficacy
Once reconstituted with bacteriostatic water, they should be kept refrigerated at 4C (39F) and used within a specific timeframe (usually 4 weeks) to prevent degradation
I used to get migraines when I was younger, but haven't had one for years